Thanks @wakefield for your ...... second post on HotCopper.
The use of caps in the thread title makes your claim appear important and more factual too.
And a screenshot from the Optum app makes it look like you've performed research and due diligence.
Well done.
Are there other solutions available in the US?
Absolutely.
Are there other solutions available locally?
Absolutely.
What happens if CVS Health enters the AU market?
Have you seen any new names enter the pharmacy industry lately?
You linked the Optum Rx app via the Google Play Store.
https://play.google.com/store/apps/details?id=com.optum.rx&hl=en_AU
Optum Rx:
Rating - 3.6
Reviews - 2,647
Downloaded - 100,000+
Let's look at MedAdvisor who (currently) only have access to the AU population.
https://play.google.com/store/apps/details?id=medadvisor.main&hl=en
MedAdvisor:
Rating - 4.6
Reviews - 3,132
Downloaded - 100,000+
Do I think MedAdvisor will be an immediate roaring success by partnering with PDX and entering the US market?
No, but one can hope. Whilst they have a vendor, MDR have performed all the heavy lifting so far. PDX will market the platform to their connected pharmacies (Giant Eagle, Lund & Byerlys, Weis, Albertsons). These names account for 15% or 10,000+ pharmacies in the US. If they can hit a third of those pharmacies or one chain they have a customer base as big as Australia. Fantasy or fiction is yet to be played out.
What am I looking forward to?
The JV with Zuellig. Zuellig own 40% of EBOS who invested $10M into MedAdvisor. EBOS bought shares on market at 5.75c. The 50/50 terms suggest both parties are serious. And I'm sure EBOS will be looking to capitalise on this investment.
Why is there less than 500 pages views a month on HC?
- People are waiting for news.
- MDR isn't a love heart and minion stock.
- The register is tightly held so traders don't play it.
I do hope you'll stick around but I'm going to assume you might just be a hand grenade poster.
Add to My Watchlist
What is My Watchlist?
